Tsur A - Search Results

1

[The guidelines for the diagnosis prevention and treatment of type 2 diabetes mellitus--2005].

Tsur A, Harman-Bohem I, Buchs AE, Raz I, Wainstein J. Tsur A, et al. Harefuah. 2006 Aug;145(8):583-6, 630. Harefuah. 2006. PMID: 16983842 Hebrew.

2

Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients.

Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ. Leibowitz G, et al. Among authors: tsur a. Clin Endocrinol (Oxf). 1996 Jun;44(6):717-22. doi: 10.1046/j.1365-2265.1996.737558.x. Clin Endocrinol (Oxf). 1996. PMID: 8759185

3

[Primary care for type 2 diabetes].

Tsur A, Harman-Boehm I, Wainstein J, Raz I. Tsur A, et al. Harefuah. 2004 May;143(5):353-4, 390. Harefuah. 2004. PMID: 15190847 Hebrew.

4

Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.

Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Tsur A, et al. Diabetes Care. 2013 May;36(5):1361-7. doi: 10.2337/dc12-1050. Epub 2013 Feb 7. Diabetes Care. 2013. PMID: 23393216 Free PMC article.

5

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators. de Zeeuw D, et al. N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9. N Engl J Med. 2013. PMID: 24206459 Free PMC article. Clinical Trial.

6

Disrupting mitochondrial-nuclear coevolution affects OXPHOS complex I integrity and impacts human health.

Gershoni M, Levin L, Ovadia O, Toiw Y, Shani N, Dadon S, Barzilai N, Bergman A, Atzmon G, Wainstein J, Tsur A, Nijtmans L, Glaser B, Mishmar D. Gershoni M, et al. Among authors: tsur a. Genome Biol Evol. 2014 Sep 22;6(10):2665-80. doi: 10.1093/gbe/evu208. Genome Biol Evol. 2014. PMID: 25245408 Free PMC article.

7

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators. Wiviott SD, et al. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.

8

Utilizing the glucose challenge test during pregnancy as a predictor of future diabetes risk.

Frankel M, Tsur N, Pollack R, Tsur A. Frankel M, et al. Among authors: tsur a. BMC Pregnancy Childbirth. 2024 Oct 11;24(1):663. doi: 10.1186/s12884-024-06874-5. BMC Pregnancy Childbirth. 2024. PMID: 39394076 Free PMC article.

9

Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study.

Tsur A, Cahn A, Israel M, Feldhamer I, Hammerman A, Pollack R. Tsur A, et al. Diabetes Metab Res Rev. 2021 Jan;37(1):e3355. doi: 10.1002/dmrr.3355. Epub 2020 Jul 3. Diabetes Metab Res Rev. 2021. PMID: 32469094

10

Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control.

Eldor R, Roitman E, Merzon E, Toledano Y, Alves C, Tsur A. Eldor R, et al. Among authors: tsur a. Endocr Pract. 2022 May;28(5):472-478. doi: 10.1016/j.eprac.2022.02.004. Epub 2022 Feb 12. Endocr Pract. 2022. PMID: 35167952 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters